Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Ovulation induction and cancer risk.

Brinton LA, Moghissi KS, Scoccia B, Westhoff CL, Lamb EJ.

Fertil Steril. 2005 Feb;83(2):261-74; quiz 525-6. Review.

PMID:
15705362
2.

Long-term effects of ovulation-stimulating drugs on cancer risk.

Brinton L.

Reprod Biomed Online. 2007 Jul;15(1):38-44. Review.

PMID:
17623533
3.

Ovarian cancer risk after the use of ovulation-stimulating drugs.

Brinton LA, Lamb EJ, Moghissi KS, Scoccia B, Althuis MD, Mabie JE, Westhoff CL.

Obstet Gynecol. 2004 Jun;103(6):1194-203.

PMID:
15172852
4.

Infertility as a cancer risk factor - a review.

Cetin I, Cozzi V, Antonazzo P.

Placenta. 2008 Oct;29 Suppl B:169-77. doi: 10.1016/j.placenta.2008.08.007. Review.

5.

Induction of ovulation and ovarian cancer: a critical review of the literature.

Mahdavi A, Pejovic T, Nezhat F.

Fertil Steril. 2006 Apr;85(4):819-26. Epub 2006 Mar 9. Review.

PMID:
16580355
6.

Ovulation inducing agents and cancer risk: review of literature.

Impicciatore GG, Tiboni GM.

Curr Drug Saf. 2011 Sep 1;6(4):250-8. Review.

PMID:
22129320
7.

In vitro fertilization and breast cancer risk: a review.

Salhab M, Al Sarakbi W, Mokbel K.

Int J Fertil Womens Med. 2005 Nov-Dec;50(6):259-66. Review.

PMID:
16526416
8.

Association between fertility drugs and gynecologic cancers, breast cancer, and childhood cancers.

Ayhan A, Salman MC, Celik H, Dursun P, Ozyuncu O, Gultekin M.

Acta Obstet Gynecol Scand. 2004 Dec;83(12):1104-11. Review.

PMID:
15548140
9.

Breast cancer risk associated with ovulation-stimulating drugs.

Brinton LA, Scoccia B, Moghissi KS, Westhoff CL, Althuis MD, Mabie JE, Lamb EJ.

Hum Reprod. 2004 Sep;19(9):2005-13. Epub 2004 Jun 24.

PMID:
15217997
10.

Childhood tumor risk after treatment with ovulation-stimulating drugs.

Brinton LA, Kr├╝ger Kjaer S, Thomsen BL, Sharif HF, Graubard BI, Olsen JH, Bock JE.

Fertil Steril. 2004 Apr;81(4):1083-91.

PMID:
15066468
11.

Fertility drugs and ovarian cancer.

Artini PG, Fasciani A, Cela V, Battaglia C, de Micheroux AA, D'Ambrogio G, Genazzani AR.

Gynecol Endocrinol. 1997 Feb;11(1):59-68. Review.

PMID:
9086341
12.

Ovarian cancer in infertility patients.

Burmeister L, Healy DL.

Ann Med. 1998 Dec;30(6):525-8. Review.

PMID:
9920353
13.

Cancer risk associated with subfertility and ovulation induction: a review.

Klip H, Burger CW, Kenemans P, van Leeuwen FE.

Cancer Causes Control. 2000 Apr;11(4):319-44. Review.

PMID:
10843444
15.

Fertility drugs and gynecologic cancer.

Kanakas N, Mantzavinos T.

Ann N Y Acad Sci. 2006 Dec;1092:265-78. Review.

PMID:
17308150
16.

Critical evaluation of the cancer risk of dibromochloropropane (DBCP).

Clark HA, Snedeker SM.

J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2005;23(2):215-60. Review.

PMID:
16291528
17.

Risk of breast cancer after exposure to fertility drugs: results from a large Danish cohort study.

Jensen A, Sharif H, Svare EI, Frederiksen K, Kjaer SK.

Cancer Epidemiol Biomarkers Prev. 2007 Jul;16(7):1400-7. Epub 2007 Jun 21.

18.
19.

Ovulation induction, assisted conception and childhood cancer.

Lightfoot T, Bunch K, Ansell P, Murphy M.

Eur J Cancer. 2005 Mar;41(5):715-24; discussion 725-6. Review.

PMID:
15763647
20.

Ovarian cancer and fertility medications: a critical appraisal.

Kashyap S, Davis OK.

Semin Reprod Med. 2003 Feb;21(1):65-71.

PMID:
12806561

Supplemental Content

Support Center